• $2.3M
    Market Cap
  • -92.60%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
01/31/2026
01/31/2025
01/31/2024
01/31/2023
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
0
-100.00%
Cost of Revenue
0
N/A
N/A
N/A
0
-100.00%
3.3M
-5.99%
Gross Profit
0
N/A
0
N/A
0
+100.00%
-3.3M
-261.17%
Sales and Marketing Expense
385,411
-43.31%
679,914
-39.22%
1.1M
+32.40%
844,836
+43.95%
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
9,957
0.00%
9,957
-33.89%
15,062
0.00%
15,062
+80.15%
Total Operating Expenses
0
-100.00%
679,914
N/A
0
-100.00%
3.3M
-5.99%
Operating Profit
-385,411
-43.31%
-679,914
-39.22%
-1.1M
-73.23%
-4.2M
+182.08%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
0
-100.00%
8,059
N/A
Income before Taxes
-385,411
-43.31%
-679,914
-39.22%
-1.1M
-73.17%
-4.2M
+181.53%
Income Taxes
29,957
-68.47%
95,008
N/A
0
+100.00%
-5,381
-102.48%
Extraordinary Items
N/A
N/A
0
-100.00%
10,449
N/A
N/A
N/A
Net Income
-415,368
-46.40%
-774,922
-30.72%
-1.1M
-73.14%
-4.2M
+229.46%
Net Income from Continuing Operations Applicable to Common
-385,411
-43.31%
-679,914
-39.22%
-1.1M
-73.17%
-4.2M
+229.89%
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
0.00
N/A
0.00
+100.00%
-0.01
-50.00%
-0.02
N/A
Basic Weighted Average Shares
207.0M
0.00%
207.0M
0.00%
207.0M
+0.25%
206.5M
+0.26%
Diluted Weighted Average Shares
207.0M
0.00%
207.0M
0.00%
207.0M
+0.25%
206.5M
+0.26%
Balance Sheet
Cash and Cash Equivalents
2,084
+666.18%
272
+1,992.31%
13
-99.96%
29,656
-72.34%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2,084
+666.18%
272
+1,992.31%
13
-99.96%
29,656
-72.34%
Total Current Assets
10,527
+3,770.22%
272
-98.85%
23,627
-94.59%
437,078
-85.73%
Accumulated Depreciation
58,399
+20.55%
48,442
+25.87%
38,485
+64.30%
23,423
N/A
Property and Plant and Equipment and Net
4,149
-70.59%
14,106
-41.38%
24,063
-51.46%
49,574
-23.30%
Total Long-Term Assets
4,149
-70.59%
14,106
-87.60%
113,715
-65.42%
328,870
-39.35%
Total Assets
14,676
+2.07%
14,378
-89.53%
137,342
-82.07%
765,948
-78.75%
Income Taxes Payable
344,234
+9.73%
313,722
+43.44%
218,714
0.00%
218,714
+0.74%
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.4M
+10.32%
4.0M
+15.54%
3.5M
+13.63%
3.1M
+97.14%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
0
N/A
0
N/A
0
-100.00%
93,334
-80.13%
Total Liabilities
4.4M
+10.32%
4.0M
+15.54%
3.5M
+10.28%
3.2M
+56.05%
Retained Earnings
-5.7M
+7.86%
-5.3M
+17.20%
-4.5M
+33.02%
-3.4M
+314.83%
Total Stockholders Equity
-4.4M
+10.34%
-4.0M
+19.85%
-3.4M
+39.80%
-2.4M
-251.91%
Total Shares Outstanding
207.0M
0.00%
207.0M
0.00%
207.0M
0.00%
207.0M
-1.26%
Cash Flow
Cash from Operating Activities
-2,688
-81.68%
-14,675
-57.98%
-34,920
-54.97%
-77,556
-191.45%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4,500
-69.87%
14,934
+183.00%
5,277
N/A
0
-100.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-2,859.28%
+179.91%
-1,021.52%
+312.46%
-247.66%
+29.95%
-190.59%
+185.99%
Return on Equity
9.84%
-53.26%
21.04%
-45.95%
38.93%
-96.17%
1,017.00%
+773.40%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
-100.00%
-104.63%
Current Ratio
0.002
+2,300.00%
0.0001
-98.53%
0.007
-95.22%
0.14
-92.76%
Cash Ratio
0.0005
+400.00%
0.0001
N/A
0.00
-100.00%
0.010
-85.92%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow